# A Systems Biology Model for Gaslighted Allodynic Fatigue (GASLIT-AF) in Post-COVID Syndromes

## Abstract

Chronic multi-system syndromes following COVID-19 infection or vaccination remain poorly understood and often underrecognized by conventional linear models. We present GASLIT-AF (Gaslighted Allodynic Fatigue) as a nonlinear systems biology framework to explain the irreversible neuro-immune dysfunction observed in a subset of patients. We formulate a recursive dynamical model of the neuroimmune loop with cognitive-limbic feedback, persistent immune activation, and hysteresis. The model is defined by six attractor parameters – **γ** (genetic susceptibility), **Λ** (allostatic load), **Ω** (buffering capacity), **σ** (systemic noise), **Θ** (recursive time delay), and **Ξ** (collapse index) – which together govern the system’s trajectories. We derive a set of coupled nonlinear differential equations incorporating these parameters and demonstrate how, beyond critical thresholds, the system can enter a pathological attractor state representing chronic illness. Recent empirical findings from 2022–2025 provide validation for each model component: persistent SARS-CoV-2 spike protein and latent virus reactivation driving immune persistence​[news.yale.edu](https://news.yale.edu/2025/02/19/immune-markers-post-vaccination-syndrome-indicate-future-research-directions#:~:text=When%20the%20researchers%20measured%20levels,associated%20with%20long%20COVID%20as%C2%A0well)​[nih.gov](https://www.nih.gov/news-events/nih-research-matters/immune-hormonal-features-long-covid#:~:text=reduced%20levels%20of%20certain%20immune,cells); cerebellar and hippocampal inflammation indicative of neuroimmune feedback​[pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10208918/#:~:text=Since%20the%20hippocampus%20is%20predominantly,a%20window%20to%20explain%20memory); autonomic dysregulation (POTS) reflecting network instability​[nature.com](https://www.nature.com/articles/s41569-023-00842-w#:~:text=tests2%20,have%20been%20also%20reported%2025); and distinctive immune/hormonal profiles (e.g. low cortisol, high TNF-α T cells) consistent with reduced buffering capacity​[nih.gov](https://www.nih.gov/news-events/nih-research-matters/immune-hormonal-features-long-covid#:~:text=When%20the%20researchers%20used%20machine,levels%20of%20certain%20immune%20cells)​[news.yale.edu](https://news.yale.edu/2025/02/19/immune-markers-post-vaccination-syndrome-indicate-future-research-directions#:~:text=From%20participants%E2%80%99%20blood%20samples%2C%20the,blood%20cells%20%E2%80%94%20among%20other%C2%A0differences). GASLIT-AF predicts an irreversible attractor in genetically susceptible individuals (e.g. with TNXB, COMT, TLR4, or certain HLA variants) when subjected to high cumulative stress or immunogenic load​[pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11562751/#:~:text=The%20Val158Met%20polymorphism%20was%20significantly,dopamine%20should%20be%20further%20explored)​[immunologyresearchjournal.com](https://www.immunologyresearchjournal.com/articles/human-leukocyte-antigen-hla-at-the-root-of-persistent-antigens-and-long-covid#:~:text=Here%20we%20offer%20a%20perspective,COVID%20and%20pave%20the%20way). We contrast this complex attractor behavior with conventional linear epidemiological approaches, illustrating why traditional models fail to capture the entrenched nature of post-COVID and post-vaccination syndromes. Finally, we discuss implications for clinical classification of these syndromes as distinct disease states, the foreseeability of harm (and thus potential legal liability) when such outcomes are predictable, and policy interventions aimed at breaking the institutional feedback loop that perpetuates dismissal and inadequate management.

## Introduction

Post-acute and post-immunization syndromes – such as _Long COVID_ after SARS-CoV-2 infection and _post-vaccination syndrome (PVS)_ after COVID-19 vaccination – have emerged as chronic conditions characterized by debilitating fatigue, pain, dysautonomia, and cognitive impairment. These syndromes present a heterogeneous array of symptoms (over 200 reported in Long COVID​[nih.gov](https://www.nih.gov/news-events/nih-research-matters/immune-hormonal-features-long-covid#:~:text=Some%20people%20may%20experience%20chronic,to%20Long%20COVID%20remain%20unclear)) including exercise intolerance, “brain fog” (cognitive dysfunction), sleep disturbances, and orthostatic intolerance​[news.yale.edu](https://news.yale.edu/2025/02/19/immune-markers-post-vaccination-syndrome-indicate-future-research-directions#:~:text=Some%20of%20the%20most%20common,understand%20the%20prevalence%20of%20PVS)​[nih.gov](https://www.nih.gov/news-events/nih-research-matters/immune-hormonal-features-long-covid#:~:text=Some%20people%20may%20experience%20chronic,to%20Long%20COVID%20remain%20unclear). Notably, they often occur in individuals with initially mild or even asymptomatic acute illness​[nature.com](https://www.nature.com/articles/s41569-023-00842-w#:~:text=The%20post,and%20treatment%20is%20still%20unsatisfactory), and can develop even after prophylactic interventions (vaccination) intended to prevent severe disease​[nature.com](https://www.nature.com/articles/s41569-023-00842-w#:~:text=The%20post,and%20treatment%20is%20still%20unsatisfactory). The prevalence is substantial – an estimated 10–30% of COVID-19 survivors experience prolonged symptoms beyond 12 weeks​[pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC9538037/#:~:text=Post%E2%80%90viral%20fatigue%20after%20SARS%E2%80%90CoV%E2%80%902%20infection,EBV%29%20or)​[clinicallab.com](https://www.clinicallab.com/long-covid-19-symptoms-likely-caused-by-epstein-barr-virus-reactivation-25749#:~:text=Epstein,published%20in%20the%20journal%20Pathogens) – yet these conditions have historically been underdiagnosed and dismissed by medical institutions. Indeed, PVS remains “unrecognized by medical authorities” despite clear patient reports of chronic illness following vaccination​[news.yale.edu](https://news.yale.edu/2025/02/19/immune-markers-post-vaccination-syndrome-indicate-future-research-directions#:~:text=COVID,is%20known%20about%20its%20biological%C2%A0underpinnings), and Long COVID patients have often been _“gaslighted”_ (told their persistent symptoms are psychosomatic) due to normal routine test results. This gap between patient experience and institutional recognition motivates a new framework to understand the pathophysiology.

Linear models of disease, as used in traditional epidemiology and acute care, struggle to explain these chronic, relapsing-remitting syndromes. In a linear framework, one expects a monotonic recovery once the acute insult (infection or vaccine) subsides, with any long-term sequelae attributable to permanent organ damage or ongoing identifiable pathology. However, many post-COVID cases defy this expectation: patients with no organ damage and initially benign courses develop systemic dysfunction months later​[clinicallab.com](https://www.clinicallab.com/long-covid-19-symptoms-likely-caused-by-epstein-barr-virus-reactivation-25749#:~:text=Epstein,published%20in%20the%20journal%20Pathogens). Conventional models also have difficulty accounting for the disproportionate impact on certain individuals (often young, previously healthy women​[nature.com](https://www.nature.com/articles/s41569-023-00842-w#:~:text=surviving%20the%20acute%20infection%2C%20which,cardiovascular%20autonomic%20dysfunction%2C%20such%20as)) and the apparent _point of no return_ after which patients remain ill indefinitely. As a result, these syndromes have been frequently miscategorized as psychological. There is a need for a **systems biology approach** that can capture feedback loops, threshold effects, and the emergent _attractor states_ observed in chronic post-viral illness.

In this work, we synthesize the GASLIT-AF (Gaslighted Allodynic Fatigue) hypothesis into a formal theoretical model. GASLIT-AF posits that chronic illness (exemplified by conditions like Long COVID, PVS, or ME/CFS) represents a self-sustaining _attractor_ in the body’s regulatory dynamics – essentially, “_when the equations of your body no longer balance_.” Instead of eventually returning to a healthy equilibrium, the system becomes trapped in a maladaptive state due to interacting positive feedback loops in the neuroimmune and neuroendocrine network. We develop a set of nonlinear differential equations to represent the **neuro-immune loop** (cross-talk between the immune system and central/autonomic nervous system), **cognitive-limbic feedback** (the influence of chronic stress, pain perception, and limbic brain activity on physiology), and **immune persistence** (the continued presence of viral antigens or latent co-infections that drive inflammation). Crucially, the model includes **hysteresis thresholds**, meaning that once the system shifts into the chronic illness state, simply removing the initial trigger may not revert the system – an irreversible (or hard-to-reverse) condition has taken hold.

We define six key parameters that determine an individual’s susceptibility and the dynamics of the GASLIT-AF model: genetic susceptibility (γ), allostatic load (Λ), buffering capacity (Ω), systemic noise (σ), recursive time delay (Θ), and collapse index (Ξ). These parameters formalize concepts from both systems biology and complex systems theory (e.g. allostasis, resilience, stochasticity, delayed feedback, and phase transitions). In the sections that follow, we (1) present the mathematical formulation of the GASLIT-AF model and explain the role of each parameter, (2) integrate recent empirical findings (2022–2025) that support the existence of the mechanisms posited by the model, and (3) demonstrate how the model provides novel insights – in particular, how it explains the failure of linear models to recognize these syndromes as distinct disease attractors. Finally, we discuss the broader implications: how this framework could inform new clinical classification schemes (treating Long COVID/PVS as a _systems_ disease state rather than a collection of symptoms), implications for legal accountability if harm from these syndromes is predictable and thus preventable, and policy measures to break the vicious cycle of institutional inertia (the “institutional attractor loop”) that has thus far impeded effective response to these chronic post-COVID conditions.

## Model Formulation: A Recursive Nonlinear Dynamical System

**Overview of the System:** We conceptualize the human body’s response to a severe perturbation (such as a viral infection or immune trigger) as a dynamical system with multiple interacting subsystems. In GASLIT-AF, the critical subsystems are: (i) the **immune system** (peripheral and central immune activity, including persistent inflammatory responses), (ii) the **nervous system** (central/autonomic nervous system, including neuroinflammation and autonomic regulation of organs), and (iii) the **cognitive-limbic system** (brain regions governing stress response, pain perception, and feedback to the HPA axis and autonomic centers). These subsystems form a closed-loop feedback network. For example, immune cytokines can activate microglia and astrocytes in the brain or trigger afferent vagal signaling, leading to sickness behavior, pain hypersensitivity, and dysautonomia (the **neuroimmune loop**). Conversely, chronic stress and dysregulated autonomic signaling (high sympathetic tone, low vagal tone) can impair immune regulation and maintain a pro-inflammatory state, for instance via cortisol dysfunction or catecholamine influences on immune cells​[nih.gov](https://www.nih.gov/news-events/nih-research-matters/immune-hormonal-features-long-covid#:~:text=When%20the%20researchers%20used%20machine,levels%20of%20certain%20immune%20cells)​[nih.gov](https://www.nih.gov/news-events/nih-research-matters/immune-hormonal-features-long-covid#:~:text=reduced%20levels%20of%20certain%20immune,cells) (the **cognitive-limbic feedback** on the body). This mutual reinforcement can create a positive feedback cycle. Additionally, **immune persistence** provides a sustained driver: the presence of residual viral proteins (e.g. SARS-CoV-2 spike in tissue or circulation​[news.yale.edu](https://news.yale.edu/2025/02/19/immune-markers-post-vaccination-syndrome-indicate-future-research-directions#:~:text=When%20the%20researchers%20measured%20levels,associated%20with%20long%20COVID%20as%C2%A0well)) or reactivation of latent pathogens like Epstein–Barr Virus (EBV)​[nih.gov](https://www.nih.gov/news-events/nih-research-matters/immune-hormonal-features-long-covid#:~:text=Participants%20with%20Long%20COVID%20had,recent%20reactivation%20of%20this%20virus) continuously provokes the immune system, preventing a return to baseline.

**State Variables:** We formalize this with a set of state variables that evolve in time (t). For tractability, we lump the myriad physiological variables into a few composite variables representing major axes of dysfunction:

- I(t)I(t)I(t) – **Immune activation/inflammation level.** This represents the overall burden of pro-inflammatory activity and immune system stress. It encapsulates elevated cytokines, activated microglia, and ongoing immune responses to any persisting antigens. High III correlates with symptoms like fatigue, malaise, and immune-mediated damage.
    
- N(t)N(t)N(t) – **Neural dysregulation level.** This captures the state of the nervous system, including autonomic imbalance (e.g. sympathetic overdrive, vagal withdrawal), central sensitization to pain (allodynia), and neuroinflammatory changes in the brain (e.g. glial activation in cerebellum and hippocampus). High NNN is reflected by symptoms such as orthostatic intolerance (POTS), sensory sensitivity, brain fog, and mood disturbances.
    
- H(t)H(t)H(t) – **Cognitive-limbic drive/stress.** This variable represents the input from higher brain centers (limbic system, hypothalamus) that modulate physiology. It can be thought of as the aggregate of psychological stress, perceived illness threat, and HPA-axis output (cortisol). High HHH implies chronic stress signaling, which can amplify NNN and suppress effective immune regulation if cortisol is deficient or maladaptive.
    

These variables are tightly coupled. We propose a set of **nonlinear ordinary differential equations (ODEs)** to describe their evolution:

dIdt=−αI I  +  f_I(N(t−Θ), Λ, γ)  +  uI(t)  +  σ ξI(t),dNdt=−αN N  +  f_N(I(t−Θ), H(t−Θ))  +  σ ξN(t),dHdt=−αH H  +  f_H(N(t), external stress),\begin{aligned} \frac{dI}{dt} &= -\alpha_I \, I \;+\; f\_I(N(t-\Theta),\, \Lambda,\, \gamma)\;+\; u_I(t)\;+\; \sigma\, \xi_I(t), \\ \frac{dN}{dt} &= -\alpha_N \, N \;+\; f\_N(I(t-\Theta),\, H(t-\Theta))\;+\; \sigma\, \xi_N(t), \\ \frac{dH}{dt} &= -\alpha_H \, H \;+\; f\_H(N(t),\, \text{external stress}), \end{aligned}dtdI​dtdN​dtdH​​=−αI​I+f_I(N(t−Θ),Λ,γ)+uI​(t)+σξI​(t),=−αN​N+f_N(I(t−Θ),H(t−Θ))+σξN​(t),=−αH​H+f_H(N(t),external stress),​

where fI,fN,fHf_I, f_N, f_HfI​,fN​,fH​ are nonlinear functions describing the feedback effects, and each equation includes: a natural decay term (−αXX-\alpha_X X−αX​X, modeling homeostatic restoration forces that dampen the variable toward baseline), a delayed feedback input (with delay Θ\ThetaΘ), and a noise term (σ ξX(t)\sigma\,\xi_X(t)σξX​(t), representing stochastic fluctuations or random stressors with amplitude σ). The term uI(t)u_I(t)uI​(t) in the immune equation represents persistent exogenous input – e.g. **antigenic persistence**. It can be a constant or time-varying source reflecting viral protein remnants or reactivating latent infections. Below, we describe the specific forms and roles of these terms:

- **Immune Feedback Function fI(N,Λ,γ)f_I(N, \Lambda, \gamma)fI​(N,Λ,γ):** This function captures how neural dysregulation feeds into immune activation. For instance, if NNN is high (autonomic dysfunction), it might trigger immune changes via neuroimmune reflexes or insufficient cortisol response. A simple choice is fI(N)=β Np/(1+Np)f_I(N) = \beta\,N^p/(1 + N^p)fI​(N)=βNp/(1+Np), a sigmoidal (Hill) function indicating that beyond a certain level of neural dysregulation, immune activity sharply increases (e.g. due to vagal withdrawal removing an anti-inflammatory brake). The parameter β\betaβ could be scaled by **γ** (genetic susceptibility) and **Λ** (allostatic load): individuals with high genetic risk or heavy prior stress burden may have an exaggerated immune response to a given neural input. Thus, β=β0 γ Λ\beta = \beta_0 \,\gamma\,\Lambdaβ=β0​γΛ could model the immune amplifier effect of genetics and stress. Importantly, uI(t)u_I(t)uI​(t) would represent persistent stimuli such as low-level viral presence; for example, uI=κu_I = \kappauI​=κ (constant) if a viral antigen remains in tissue, keeping III from ever fully decaying to zero.
    
- **Neural Feedback Function fN(I,H)f_N(I, H)fN​(I,H):** This term reflects how immune activity and cognitive-limbic signals drive neural dysregulation. Immune cytokines can cause blood–brain barrier disruption and neuroinflammation, raising NNN​[nature.com](https://www.nature.com/articles/s41593-024-01576-9#:~:text=Vascular%20disruption%20has%20been%20implicated,Accordingly%2C%20peripheral%20blood%20mononuclear%20cells)​[pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10208918/#:~:text=Since%20the%20hippocampus%20is%20predominantly,a%20window%20to%20explain%20memory). We can use a Hill-type function fN(I)=γI Iq/(1+Iq)f_N(I) = \gamma_I\, I^q/(1 + I^q)fN​(I)=γI​Iq/(1+Iq) to model immune-driven neural activation once inflammation crosses a threshold. Additionally, psychological stress or arousal (H) can exacerbate autonomic dysfunction; for example, chronic stress might desensitize baroreflex or increase sympathetic output, contributing additively to NNN. Thus, fNf_NfN​ might sum an immune component and a stress component: fN(I,H)=γI g(I)+γHHf_N(I,H) = \gamma_I\, g(I) + \gamma_H HfN​(I,H)=γI​g(I)+γH​H, where g(I)g(I)g(I) is sigmoidal in III. The **recursive time delay (Θ)** is applied in the coupling terms to reflect delays like cytokine signaling times or HPA axis latency (e.g. it takes time for immune changes to influence brain function and vice versa). A delay can produce oscillations or overshoot, but here it also contributes to potential instability and path dependence.
    
- **Cognitive-Limbic Dynamics fH(N)f_H(N)fH​(N):** We include H(t)H(t)H(t) primarily to capture how chronic symptoms feed back into stress. For instance, persistent pain and fatigue (high NNN) can lead to frustration, anxiety or PTSD-like phenomena in patients​[pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10378471/#:~:text=In%20the%20aftermath%20of%20COVID,The%20full%20effect), which in turn may further dysregulate the HPA axis. We might model fH(N)f_H(N)fH​(N) as a proportional relationship γNN \gamma_N NγN​N for simplicity – higher neural distress leads to higher limbic activation (e.g. anxiety). Meanwhile, αHH\alpha_H HαH​H term would normally bring stress down (through adaptation or exhaustion). In chronic illness, one could interpret a low αH\alpha_HαH​ (or even HHH “stuck” at a high level due to continuous symptoms).
    

**Attractor Dynamics and Hysteresis:** The above system can exhibit **bistability** or multistability under certain parameter regimes. Intuitively, there may be two (or more) equilibrium states: a _healthy state_ (low I,N,HI, N, HI,N,H) and a _chronic illness state_ (high I,N,HI, N, HI,N,H), with the latter being a self-perpetuating attractor. The transition between them may occur when a combination of γ, Λ, and external trigger magnitude pushes the system past a tipping point. This can be illustrated by analyzing steady-state solutions. In a simplified form, consider the steady-state of III and NNN ignoring delay and noise:

I∗=β (N∗)p1+(N∗)p+uI,N∗=γI (I∗)q1+(I∗)q+γHH∗.I^* = \frac{\beta\, (N^*)^p}{1 + (N^*)^p} + u_I, \qquad N^* = \frac{\gamma_I\, (I^*)^q}{1 + (I^*)^q} + \gamma_H H^*.I∗=1+(N∗)pβ(N∗)p​+uI​,N∗=1+(I∗)qγI​(I∗)q​+γH​H∗.

At baseline (pre-illness), uI=0u_I = 0uI​=0 (no persistent antigen) and H∗≈0H^* \approx 0H∗≈0 (no chronic stress), so a trivial solution is I∗≈0,N∗≈0I^* \approx 0, N^* \approx 0I∗≈0,N∗≈0. If parameters are such that the feedback gains (βγI\beta \gamma_IβγI​, etc.) are low, this healthy equilibrium is stable. However, **high genetic susceptibility (γ)** and **high allostatic load (Λ)** effectively increase the gains, and a sufficiently large perturbation (e.g. a major infection) can lead to a _saddle-node bifurcation_: beyond a threshold, the trivial equilibrium disappears and the system’s trajectory flows toward a new stable high-III, high-NNN equilibrium. We designate the point at which this qualitative change occurs as the **collapse threshold**, associated with the **collapse index (Ξ)**.

Mathematically, we can define **Ξ** as a composite parameter that indicates how close the system is to irreversible collapse. One conceptual definition is:

Ξ=γ ΛΩ,\Xi = \frac{\gamma \,\Lambda}{\Omega},Ξ=ΩγΛ​,

where **Ω** (buffering capacity) moderates the impact of susceptibility (γ) and load (Λ). Ω represents the strength of negative feedback (the rates αI,αN,αH\alpha_I, \alpha_N, \alpha_HαI​,αN​,αH​ and other homeostatic reserves). A healthy system has large Ω relative to the burden, keeping Ξ < 1. If Ξ exceeds 1 (a notional threshold), homeostatic forces can no longer restore the baseline state, and the system “flips” to the illness attractor. This captures the idea that **high susceptibility × high load, when not counterbalanced by sufficient buffering, leads to collapse**. In a dynamic sense, Ξ could be time-varying as Λ accumulates or Ω is depleted; once Ξ crosses a critical value, the shift occurs (analogous to reaching the basin boundary of the healthy attractor).

Importantly, **hysteresis** means that to recover (return to the healthy state), simply reversing the initial trigger is not enough – one would have to drastically reduce γ or Λ or boost Ω far more than the amount by which they crossed the threshold. In practice, this could mean that even if the acute infection is gone and stress is reduced, the person remains ill because the internal feedback loops sustain the high-III, high-NNN state. The model’s phase space thus contains a region of attraction for the chronic state that, once entered, keeps the trajectory orbiting that state (persistent inflammation and neural dysregulation) unless a significant external intervention (or improbably low noise pushing the state over the basin barrier) occurs.

**Summary of GASLIT-AF Parameters:** For clarity, we summarize the six key parameters of the model and their interpretations:

- **γ (Gamma) – Genetic Susceptibility:** a dimensionless factor representing inherited predisposition to dysregulation. High γ amplifies feedback loops (e.g. stronger pro-inflammatory responses or weaker innate viral clearance). Examples: certain HLA alleles that poorly present viral antigens​[immunologyresearchjournal.com](https://www.immunologyresearchjournal.com/articles/human-leukocyte-antigen-hla-at-the-root-of-persistent-antigens-and-long-covid#:~:text=Here%20we%20offer%20a%20perspective,COVID%20and%20pave%20the%20way), _TLR4_ variants that exaggerate immune activation​[translational-medicine.biomedcentral.com](https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-023-04588-4#:~:text=Among%20the%2073%20genes%20associated,with%20potential%20to%20protect%20against), or polymorphisms like _COMT Val158Met_ that affect pain processing​[pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11562751/#:~:text=The%20Val158Met%20polymorphism%20was%20significantly,dopamine%20should%20be%20further%20explored). These make the system more prone to tipping into chronic inflammation or central sensitization.
    
- **Λ (Lambda) – Allostatic Load:** the cumulative burden of stressors (biological or psychosocial) on the system. This could be prior illnesses, trauma, chronic stress, or environmental load. Λ effectively shifts the baseline closer to the tipping point by weakening homeostasis. For instance, multiple infections (SARS-CoV-2 plus other viruses) or repeated exposures (e.g. successive vaccinations or stress during the pandemic) add to Λ. A high Λ means the system is already strained **before** the trigger, leaving less adaptive capacity.
    
- **Ω (Omega) – Buffering Capacity:** the resilience or reserve that counters perturbations. This encompasses robust anti-inflammatory responses, efficient viral clearance, strong autonomic flexibility, and endocrine balance. High Ω (robust buffers) can absorb shocks without permanent state change – e.g. a healthy HPA axis that releases sufficient cortisol to dampen inflammation (notably, long COVID patients show _low_ cortisol, indicating deficient buffering​[nih.gov](https://www.nih.gov/news-events/nih-research-matters/immune-hormonal-features-long-covid#:~:text=When%20the%20researchers%20used%20machine,levels%20of%20certain%20immune%20cells)). Nutritional status, metabolic health, and youthful tissue repair capacity also contribute to Ω.
    
- **σ (Sigma) – Systemic Noise:** the level of random fluctuations and external perturbations. In physiology, this could be day-to-day variations or co-insults (minor infections, toxins, psychological triggers). In our equations, σ scales the stochastic term ξ(t)\xi(t)ξ(t). Even if deterministic dynamics have two attractors, noise can induce jumps between states or push a marginally stable system into collapse. High σ might represent a chaotic environment or ongoing microstress (for example, intermittent reactivation of EBV adding random immune stress).
    
- **Θ (Theta) – Recursive Time Delay:** the effective delay in feedback loops. Finite delays in signaling (e.g. time for immune cells to migrate, or for HPA axis hormones to act) can destabilize an otherwise stable negative feedback loop, contributing to oscillations or overshoot. Θ is measured in time units (hours to days) in our context. For example, the time for an acute infection to trigger EBV reactivation and for that to feed back into illness might span weeks​[pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC9538037/#:~:text=participants%20up%20to%2010%20weeks,in%20a%20sub%E2%80%90group%20of%20patients). Longer delays can worsen overshoot – by the time the system responds, it overshoots the mark, fueling chronic dysfunction.
    
- **Ξ (Xi) – Collapse Index:** an aggregate measure of how close the system is to a permanent collapse into the illness attractor. While not an independent input (it’s a function of the other parameters and current state), we treat Ξ as a parameter indicating the presence of an alternative stable state. It formalizes the condition for bistability: when Ξ exceeds a critical value (≈1), the pathological attractor emerges and can capture the system. Clinically, one might compute Ξ from risk factors (genetic risk score, allostatic load index, etc.) to identify patients in danger of transitioning to chronic illness after a stressor.
    

In summary, the GASLIT-AF model provides a quantitative theoretical structure for a phenomenon that patients often describe qualitatively: _after a certain point, their body “crashed” and never fully recovered._ In the next section, we tie each element of this model to recent empirical findings, demonstrating that the abstract concepts of persistent inflammation, feedback loops, and genetic risk are strongly supported by biomedical research on post-COVID conditions.

## Empirical Validation of the Model Components

**Persistent Viral Antigens and Immune Persistence:** A central premise of GASLIT-AF is that a continued immune stimulus (term uI(t)u_I(t)uI​(t) in the model) sustains the illness attractor. Emerging research has confirmed that SARS-CoV-2 can leave behind persistent viral proteins in the body long after acute infection, providing exactly such a stimulus. Recent analyses of blood and tissues from Long COVID patients have found remnants of the virus (such as the spike protein) many months post-infection​[directorsblog.nih.gov](https://directorsblog.nih.gov/2024/10/31/many-people-with-long-covid-have-signs-of-persistent-sars-cov-2-proteins-new-findings-show/#:~:text=Studies%20have%20shown%20that%20for,that%20Long%20COVID%20may%20sometimes). One RECOVER study reported that people with Long COVID were **twice as likely** to have SARS-CoV-2 proteins detectable in their blood 4–7 months after infection compared to fully recovered individuals​[directorsblog.nih.gov](https://directorsblog.nih.gov/2024/10/31/many-people-with-long-covid-have-signs-of-persistent-sars-cov-2-proteins-new-findings-show/#:~:text=Studies%20have%20shown%20that%20for,that%20Long%20COVID%20may%20sometimes). Similarly, a Yale study of post-vaccination syndrome (PVS) discovered that some patients had spike protein circulating **over 700 days (nearly 2 years) after vaccination**, long past the expected clearance window​[news.yale.edu](https://news.yale.edu/2025/02/19/immune-markers-post-vaccination-syndrome-indicate-future-research-directions#:~:text=When%20the%20researchers%20measured%20levels,associated%20with%20long%20COVID%20as%C2%A0well). This persistent spike signal was observed even in PVS subjects with no evidence of natural infection, implicating the vaccine-derived antigen. The authors note that “persistent spike protein has been associated with long COVID as well”​[news.yale.edu](https://news.yale.edu/2025/02/19/immune-markers-post-vaccination-syndrome-indicate-future-research-directions#:~:text=levels%20of%20spike%20protein%20than,associated%20with%20long%20COVID%20as%C2%A0well), strengthening the parallel between post-infection and post-vaccination chronic syndromes. These findings validate the **immune persistence driver uIu_IuI​** in our model: a continuous source of antigen can maintain immune activation I(t)I(t)I(t) indefinitely, preventing resolution.

In addition to SARS-CoV-2 antigens, **herpesvirus reactivation** has emerged as another source of immune persistence. EBV, which lies dormant in most adults, can resurge under stress. A landmark 2021 study showed that **66.7% of long COVID patients had serological evidence of recent EBV reactivation**, compared to only 10% of COVID survivors without long-term symptoms​[clinicallab.com](https://www.clinicallab.com/long-covid-19-symptoms-likely-caused-by-epstein-barr-virus-reactivation-25749#:~:text=selected%20from%20those%20surveyed%2C%20that,001%2C%20Fisher%27s%20exact%20test). EBV reactivation (indicated by high EBV early antigen IgG or viral capsid IgM titers) correlated with classic long COVID complaints like fatigue and brain fog​[clinicallab.com](https://www.clinicallab.com/long-covid-19-symptoms-likely-caused-by-epstein-barr-virus-reactivation-25749#:~:text=Epstein,published%20in%20the%20journal%20Pathogens). Subsequent studies in 2022 confirmed that EBV DNA is more frequently detectable in patients with post-COVID fatigue than in fully recovered controls (50% vs 20% in one cohort)​[pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC9538037/#:~:text=prior%20to%20sampling%20,had%20recovered%20from%20their%20SARS%E2%80%90CoV%E2%80%902). These data support the model’s notion of **allostatic overload (Λ)** triggering latent infections: the inflammatory and cortisol perturbations of acute COVID-19 can “wake the sleeping giant” EBV​[academic.oup.com](https://academic.oup.com/femspd/article/doi/10.1093/femspd/ftae002/7590836#:~:text=Awakening%20the%20sleeping%20giant%3A%20Epstein%E2%80%93Barr,term%20long). Once active, EBV becomes another chronic antigenic stimulus, compounding I(t)I(t)I(t). Indeed, the NIH recently highlighted that elevated antibodies against EBV are among the strongest predictors distinguishing Long COVID patients​[nih.gov](https://www.nih.gov/news-events/nih-research-matters/immune-hormonal-features-long-covid#:~:text=Participants%20with%20Long%20COVID%20had,recent%20reactivation%20of%20this%20virus). In our framework, this means the system has an additional positive feedback: high III (from SARS-CoV-2) begets higher III (from EBV reactivation), a vicious cycle locking III into a high state.

**Neuroinflammation in the Cerebellum and Hippocampus:** A hallmark of GASLIT-AF is the neuroimmune loop, wherein brain inflammation and dysfunction (N(t)N(t)N(t)) both result from and contribute to immune activation. Mounting evidence indicates that long COVID involves measurable changes in the brain, even in patients who had mild acute illness. Neuroimaging studies using FDG-PET have identified **hypometabolism in the brains of long COVID patients**, particularly in regions like the brainstem, cerebellum, and limbic system​[pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10378471/#:~:text=cerebellum,45). In one series of 35 patients with persistent neurologic symptoms, significant reductions in glucose uptake were found in the **cerebellum and brainstem** (among other regions) compared to controls​[pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10378471/#:~:text=cerebellum,45). These areas are crucial for autonomic and cognitive function, aligning with patient symptoms (balance issues, dysautonomia, memory problems). Such hypometabolism likely reflects underlying neuroinflammation or neuronal dysfunction.

More direct evidence of neuroinflammation comes from molecular studies. One investigation into the **hippocampus** – a limbic structure involved in memory and mood – found that SARS-CoV-2 infection can activate microglia (the brain’s immune cells) and induce a **“CNS cytokine storm” in the hippocampus**, leading to a loss of neurogenesis​[pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10208918/#:~:text=Since%20the%20hippocampus%20is%20predominantly,a%20window%20to%20explain%20memory). The authors connect this to long-term cognitive deficits: reduced hippocampal neurogenesis could explain memory loss and “brain fog” in long COVID​[pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10208918/#:~:text=memory%20loss%20and%20quickening%20neurodegenerative,resultant%20loss%20of%20hippocampal%20neurogenesis). In our model, this corresponds to a sustained elevation of N(t)N(t)N(t) due to immune-driven injury in cognitive regions. Notably, hippocampal and cerebellar vulnerabilities are also seen in other post-viral fatigue syndromes; neuroinflammation in these regions was previously observed in ME/CFS patients via PET scanning of neuroimmune activation. The GASLIT-AF parameter **Θ (delay)** is relevant here: neurological complications often manifest after a delay (weeks to months post-infection), as inflammation gradually damages neural circuits or autoimmunity sets in. This delay in feedback matches clinical observations of patients who “seemed to recover, then got worse,” implying a slow feedback loop reaching criticality. It also resonates with the concept of **hysteresis** – once neural damage/inflammation is established, patients do not quickly revert to normal even if the triggering virus is gone.

Crucially, neuroinflammation doesn’t just reflect damage; it further dysregulates systemic physiology. Inflammation of the brainstem and cerebellar autonomic centers can blunt the baroreflex and vagal output, worsening POTS and orthostatic intolerance (feeding into N(t)N(t)N(t) via autonomic pathways). Likewise, hippocampal inflammation can dysregulate the hypothalamic-pituitary-adrenal (HPA) axis, leading to cortisol disturbances (which would reduce Ω, the buffering capacity). Thus, the empirical data on brain inflammation substantiates the **feedback from III to NNN** in the model, and illustrates how an initial immune insult can translate into long-term autonomic and endocrine dysfunction.

**Dysautonomia and Positive Feedback in Autonomic Circuits:** One of the most striking clinical features in long COVID and related syndromes is **dysautonomia**, particularly Postural Orthostatic Tachycardia Syndrome (POTS). Large studies and meta-analyses have now shown that a significant fraction of long COVID patients meet criteria for POTS or orthostatic intolerance. For instance, a 2023 report in _Nature Reviews Cardiology_ noted POTS as a “major phenotype” of post-acute COVID syndrome, estimated in ~30% of highly symptomatic cases​[nature.com](https://www.nature.com/articles/s41569-023-00842-w#:~:text=tests2%20,have%20been%20also%20reported%2025). Symptoms such as palpitations, lightheadedness, and exercise intolerance often overlap between POTS and long COVID cohorts​[nature.com](https://www.nature.com/articles/s41569-023-00842-w#:~:text=surviving%20the%20acute%20infection%2C%20which,cardiovascular%20autonomic%20dysfunction%2C%20such%20as)​[nature.com](https://www.nature.com/articles/s41569-023-00842-w#:~:text=be%20a%20major%20phenotype%20in,have%20been%20also%20reported%2025). Autonomic testing confirms elevated heart rate upon standing and other autonomic irregularities in post-COVID patients, even those who had mild infection. This aligns with our model’s prediction that N(t)N(t)N(t) (neural dysregulation) is persistently high.

Dysautonomia itself can create reinforcing loops. In POTS, for example, reduced venous return and autonomic mis-calibration lead to tachycardia and sometimes low blood pressure, which can cause cerebral hypoperfusion and symptoms of fatigue and cognitive haze. Chronic orthostatic stress might then trigger more sympathetic activity and catecholamine release, which is pro-inflammatory and anxiogenic – thus feeding back into I(t)I(t)I(t) and H(t)H(t)H(t). The **cognitive-limbic feedback** loop is seen in how patients develop anxiety about standing or exertion (a learned fear of symptom exacerbation), compounding sympathetic activation. Additionally, dysautonomia can impair sleep and recovery, adding to **allostatic load Λ** (each day the body struggles to maintain basic functions, accumulating stress). The prevalence of dysautonomia lends credence to GASLIT-AF’s assertion that conventional homeostatic control systems (like blood pressure and heart rate regulation) may become unstable oscillators contributing to the attractor state.

Another piece of evidence is the **striking hormonal abnormalities** tied to dysautonomia in long COVID. Researchers at Mount Sinai found that **cortisol levels were about half of normal in Long COVID patients** one year after infection​[science.org](https://www.science.org/content/article/blood-abnormalities-found-people-long-covid#:~:text=Blood%20abnormalities%20found%20in%20people,as%20fatigue%20and%20muscle). Cortisol, a key stress hormone, normally helps maintain vascular tone and dampen inflammation; low cortisol can both worsen POTS symptoms (causing low blood volume, fatigue) and fail to restrain immune activation. The same study identified low cortisol as the single strongest predictor of long COVID status, stronger than any cytokine or antibody marker​[nih.gov](https://www.nih.gov/news-events/nih-research-matters/immune-hormonal-features-long-covid#:~:text=When%20the%20researchers%20used%20machine,levels%20of%20certain%20immune%20cells). This implies a collapse of HPA axis function – a classic example of lost buffering capacity (Ω). Without adequate cortisol, the negative feedback on inflammation is weakened (small Ω in our model), allowing trivial stressors to cause outsized immune responses. It also exemplifies how _the autonomic-endocrine network itself enters a new equilibrium_: long-term hypocortisolemia could indicate the HPA axis has reset to a lower set-point, potentially via feedback from chronic inflammation (since cytokines like IL-6 can suppress adrenal function). These data underscore the integrated nature of the GASLIT-AF attractor: immune, autonomic, and endocrine changes all lock in step.

**Genetic and Polygenic Risk Factors:** Finally, the GASLIT-AF model emphasizes **γ (genetic susceptibility)** – often polygenic – as a determinant of why only some individuals progress to the chronic attractor state. There is growing evidence that genetics play a role in post-COVID syndromes, as they do in related conditions like ME/CFS and fibromyalgia. Several candidate genes and loci have come to light:

- **HLA Alleles:** The human leukocyte antigen (HLA) genes are crucial for antigen presentation and immune response. Variation in HLA could affect the clearance of SARS-CoV-2. A recent perspective proposed that **certain HLA class I alleles with low binding affinity to SARS-CoV-2 might permit viral antigen persistence, thereby predisposing to Long COVID**​[immunologyresearchjournal.com](https://www.immunologyresearchjournal.com/articles/human-leukocyte-antigen-hla-at-the-root-of-persistent-antigens-and-long-covid#:~:text=Here%20we%20offer%20a%20perspective,COVID%20and%20pave%20the%20way). In essence, if one’s HLA molecules do not effectively present key viral fragments, the infection can smolder and viral proteins linger, constantly irritating the immune system. This aligns perfectly with our model’s idea of genetic γ influencing the term uI(t)u_I(t)uI​(t) (persistent antigen) and raising Ξ (collapse risk). Determining patients’ HLA haplotypes could thus identify those at higher risk of the immune persistence loop.
    
- **TLR4 and Innate Immune Genes:** A combinatorial genetics study in late 2023 identified a set of genes associated with severe and fatigue-dominant long COVID​[translational-medicine.biomedcentral.com](https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-023-04588-4#:~:text=Combinatorial%20analysis%20identified%2073%20genes,with%20neurological%20and%20cardiometabolic%20diseases). Among the top hits were genes involved in innate immune sensing and inflammation. Notably, the authors found that **TLR4 (Toll-like receptor 4)** and its signaling network may be key, and they highlighted TLR4 antagonists as potential therapies for long COVID​[translational-medicine.biomedcentral.com](https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-023-04588-4#:~:text=TLR4%20antagonists%20as%20repurposing%20candidates,treating%20long%20COVID%20and%2For%20ME%2FCFS). TLR4 is an innate immune receptor that can be triggered by viral proteins and tissue damage signals; hyperactive variants of TLR4 could amplify the initial cytokine storm and prolong inflammation (higher γ). This finding is also intriguing given TLR4’s known role in pain sensitization (it is expressed on microglia and contributes to neuropathic pain), linking to allodynia.
    
- **Connective Tissue and Autonomic Genes (RCCX Cluster, TNXB):** Clinical observation has long noted an overlap between hypermobile Ehlers-Danlos syndrome (hEDS) and conditions like chronic fatigue and POTS. hEDS is caused by connective tissue gene variants, often in the **RCCX gene cluster** (which includes the _TNXB_ gene encoding tenascin-X). These connective tissue disorders may predispose to autonomic instability (excessive venous pooling, joint proprioceptive issues) and immune dysregulation. Indeed, patients with hEDS frequently report chronic pain, fatigue and dysautonomia​[eds.clinic](https://www.eds.clinic/articles/what-is-ehlers-danlos-syndrome#:~:text=What%20is%20Ehlers,PoTS%29). The RCCX hypothesis suggests a common genetic module linking autoimmunity, EDS, and chronic illness​[ohtwist.com](https://ohtwist.com/rccx-and-eds#:~:text=The%20RCCX%20Hypothesis%20%2F%20Theory,for%20so%20many%20major%20comorbidities). In our terms, someone with a TNXB mutation (low collagen integrity) might have high γ in both the mechanical domain (autonomic support) and immunological domain (since the RCCX cluster also contains immune-related genes). This would lower the threshold for tipping into the chronic state after a viral hit. While direct studies on TNXB in long COVID are pending, ongoing longitudinal studies may soon confirm whether hypermobility is a risk factor for post-COVID syndromes.
    
- **Neurotransmitter and Pain Modulation Genes (COMT):** The enzyme catechol-O-methyltransferase (COMT) regulates dopamine, epinephrine, and norepinephrine metabolism in the brain and body. The common COMT Val158Met polymorphism affects the enzyme’s activity and has been repeatedly associated with pain sensitivity and fatigue syndromes​[pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11562751/#:~:text=The%20Val158Met%20polymorphism%20was%20significantly,dopamine%20should%20be%20further%20explored). Fibromyalgia, which shares the allodynic fatigue features of GASLIT-AF, has been linked to the Met/Met genotype (low COMT activity leading to higher dopamine and heightened pain perception)​[pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11562751/#:~:text=The%20Val158Met%20polymorphism%20was%20significantly,dopamine%20should%20be%20further%20explored). Such individuals might experience more severe central sensitization (higher baseline NNN) and also altered immune responses because catecholamines modulate immunity. Therefore, COMT variants could contribute to the cognitive-limbic feedback gain in the model – a genetically set high gain on the pain/stress loop, increasing γ.
    

These examples illustrate that **polygenic risk** is likely crucial in determining who enters the chronic attractor. No single gene causes Long COVID; rather, an unfavorable combination (e.g. an HLA allele that fails to clear virus, a TLR4 variant that overreacts to it, a COMT variant that heightens pain from the inflammation, and a TNXB variant that limits physical compensation) could together yield a γ high enough that even moderate allostatic load pushes Ξ > 1. This aligns with the clinical observation that many long COVID patients have _personal or family histories_ of autoimmune diseases, hypermobility syndromes, or mood disorders, indicating an underlying genetic susceptibility terrain. Our model provides a framework to integrate these diverse genetic factors under one parameter (γ) and to understand how they interplay with environment (Λ, σ) to determine outcomes.

**Immune Profiling and Biomarker Alignment:** Beyond specific genes, broad immune profiling has further validated the idea that long COVID/PVS patients are in a distinct immuno-metabolic state (our illness attractor). For instance, the Yale PVS study reported **lower effector CD4+ T cells and higher TNF-α-producing CD8+ T cells** in PVS patients versus controls​[news.yale.edu](https://news.yale.edu/2025/02/19/immune-markers-post-vaccination-syndrome-indicate-future-research-directions#:~:text=From%20participants%E2%80%99%20blood%20samples%2C%20the,blood%20cells%20%E2%80%94%20among%20other%C2%A0differences). This indicates a skewed T cell response consistent with chronic immune activation or exhaustion. Likewise, multiple teams have found elevated pro-inflammatory cytokines (like IL-6, IFN-β) and markers of innate immune cell activation in long COVID patients, even many months out from infection​[nih.gov](https://www.nih.gov/news-events/nih-research-matters/immune-hormonal-features-long-covid#:~:text=The%20team%20found%20significant%20differences,levels%20of%20immune%20signaling%20molecules)​[nih.gov](https://www.nih.gov/news-events/nih-research-matters/immune-hormonal-features-long-covid#:~:text=Participants%20with%20Long%20COVID%20had,recent%20reactivation%20of%20this%20virus). These immune signatures show that I(t)I(t)I(t) remains high and qualitatively different from convalescent healthy individuals, rather than returning to a baseline. Metabolomic studies also reveal a state of sustained oxidative stress and metabolic reprogramming in long COVID, similar to that seen in chronic fatigue syndrome, supporting the notion of a stable altered state.

In summary, the past few years of research have converged on several findings – persistent viral antigens, herpesvirus reactivations, neuroinflammation, dysautonomia, endocrine dysregulation, and genetic predispositions – all of which are encapsulated by the GASLIT-AF model parameters. The **irreversible attractor** posited by the model is now evidenced by patients who, despite clearance of the virus, show continuing biological aberrations (immune and neuro). By mapping these data onto the model, we gain confidence that GASLIT-AF is not just a theoretical construct but a reflection of real pathophysiological processes.

## Discussion

**GASLIT-AF vs. Linear Models:** Traditional linear epidemiological models view post-infectious sequelae in terms of risk factors that either increase the likelihood of a complication or the magnitude of a sustained decrement in health (often assumed to decay over time). These models lack feedback loops and typically assume a return towards baseline (perhaps an exponential recovery). In contrast, GASLIT-AF describes a _qualitative_ change in system behavior – the emergence of a new stable state of ill health. This difference has profound implications:

- **Nonlinearity and Thresholds:** Linear models would predict that a larger initial insult yields more prolonged symptoms, but gradually, all patients should improve as the cause is removed. GASLIT-AF instead predicts that beyond a threshold, increasing the insult can trigger a _discontinuous jump_ into chronic illness that does not spontaneously remit. This explains why even a mild infection can sometimes precipitate a long-lasting syndrome: if the person’s Ξ was near threshold, a small push triggers collapse. Conversely, severe infection in a resilient person (low Ξ) might still result in full recovery. Thus, outcome is not proportional to initial severity – a phenomenon observed in COVID-19 (some asymptomatic acute cases developed crippling long COVID​[clinicallab.com](https://www.clinicallab.com/long-covid-19-symptoms-likely-caused-by-epstein-barr-virus-reactivation-25749#:~:text=Epstein,published%20in%20the%20journal%20Pathogens), whereas some ICU patients recovered fully). Linear frameworks, which expect proportionality, failed to foresee this.
    
- **Multiple Stable Outcomes:** In linear thinking, one might classify patients as having or not having long COVID, but assume the “long COVID” group is simply slow to recover along a continuum. GASLIT-AF posits two basins of attraction: health vs. chronic illness. This means interventions need to be thought of in terms of _shifting systems between basins_ rather than simply speeding up a recovery trajectory. It also means incidence of chronic illness can be underrecognized if measured at a single time – patients might appear recovered then later relapse into the other basin (something clinicians indeed see when patients attempt to resume normal activity and then crash). Conventional longitudinal studies not accounting for nonlinearity might misclassify such cases.
    
- **Underrecognition and Attribution:** Because linear models expect a diminishing tail of symptoms, many clinicians were initially skeptical that new, ongoing pathology was present in long COVID. GASLIT-AF, however, provides a rationale for why standard tests could appear normal: the system has reorganized at a higher-level systems level (e.g. altered neuroimmune signaling) that isn’t captured by static snapshots of organ function. It explains why patients might have disabling fatigue with “normal” cardiac and lung tests – the dysfunction is in the network (immune-brain signaling, metabolic energetics), not an organ failing linearly. This complex pathology is easy to dismiss if one is only looking for linear damage (e.g. scar tissue or persistent viremia). Thus, the framework directly addresses why these syndromes were _gaslighted_: they don’t follow the expected linear model of disease and thus were falsely presumed psychosomatic.
    
- **Epidemiological Signals:** A practical contrast is in prevalence estimation. A linear model might average outcomes and dilute signals – for instance, if 10% have long COVID and 90% recover, a linear model might treat 10% as just the slow extreme of a recovery distribution. GASLIT-AF suggests treating that 10% as a separate population in a different state. This sharpened view can highlight risk factors and mechanisms (as we saw with genetic associations). It also implies that interventions should aim to prevent susceptible individuals from tipping into that state, rather than treating everyone the same post-infection.
    

**Clinical Classification and Research Implications:** Viewing post-COVID/PVS conditions as an attractor state encourages a reclassification from symptom-based syndromes to a **disease entity defined by a systems biology signature**. Just as we classify “diabetes” by an inability to regulate blood glucose, we might classify GASLIT-AF conditions by an inability to down-regulate inflammation and autonomic activity after a trigger. Clinically, this could mean developing diagnostic criteria that include biomarkers like _persistent viral antigen, evidence of herpesvirus reactivation, autonomic testing abnormalities, and hormonal aberrations_ – which together indicate the patient is in the GASLIT-AF state. Some progress is being made: for example, the finding that low cortisol and high EBV antibodies are strong predictors could form part of a diagnostic panel​[nih.gov](https://www.nih.gov/news-events/nih-research-matters/immune-hormonal-features-long-covid#:~:text=When%20the%20researchers%20used%20machine,levels%20of%20certain%20immune%20cells). As our model implies, a combination of such markers (rather than any single one) defines the state.

Additionally, the model suggests subtyping patients by which feedback loops dominate. For instance, some might be more immune-centric (high cytokines, autoantibodies), others more autonomic-centric (severe POTS, small fiber neuropathy), and others more limbic-centric (severe cognitive dysfunction, pain amplification). All fall under GASLIT-AF but with different emphases of I,N,HI, N, HI,N,H. Recognizing these patterns can guide targeted therapies: e.g. immune-centric cases might benefit from antivirals or anti-inflammatories, autonomic cases from volume expansion and beta-blockers, limbic cases from neuro-modulators or neuroplasticity therapies. The model effectively provides a blueprint for a **systems medicine approach**, integrating immunology, neurology, and endocrinology.

For research, GASLIT-AF highlights the need for longitudinal and interventional studies that examine feedback, not just one-time correlations. For example, trials of cortisol replacement in long COVID (to boost Ω) could test if breaking one feedback loop (HPA axis dysfunction) can pull patients out of the attractor. Similarly, antiviral treatments for persistent reservoirs (to reduce uIu_IuI​) or Vagus nerve stimulation (to increase parasympathetic braking on inflammation) are logical extensions of targeting model components. Indeed, some early trials of antivirals (for EBV or SARS-CoV-2) and neuromodulators are underway, spurred by such hypotheses. Our model helps justify these as part of an overall framework rather than ad-hoc symptom management.

**Legal Liability and Predictable Harm:** If we accept the GASLIT-AF model and the evidence supporting it, an implication is that severe chronic illness following COVID-19 or vaccination is not a random fluke but, in some individuals, a **predictable outcome of system dynamics**. This raises questions of accountability. For instance, consider public health policy and vaccine rollout: at the population level, vaccines have immense benefit, but our model (and now data) indicate a small subset of recipients with certain risk factors (high γ and Λ) could develop PVS – a chronic condition triggered by the vaccine​[news.yale.edu](https://news.yale.edu/2025/02/19/immune-markers-post-vaccination-syndrome-indicate-future-research-directions#:~:text=COVID,is%20known%20about%20its%20biological%C2%A0underpinnings). Traditionally, rare adverse events might be dismissed as coincidence unless a direct linear link is proven. GASLIT-AF provides a mechanistic link: if someone with known EDS and autoimmune tendencies (genetic predispositions) and high stress load takes an mRNA vaccine, and we know persistent spike protein can drive chronic inflammation​[news.yale.edu](https://news.yale.edu/2025/02/19/immune-markers-post-vaccination-syndrome-indicate-future-research-directions#:~:text=When%20the%20researchers%20measured%20levels,associated%20with%20long%20COVID%20as%C2%A0well), then a resulting chronic syndrome is _to some extent foreseeable_.

From a legal standpoint, this could translate to **duty of care** in identifying high-risk individuals and monitoring or mitigating their risk when undergoing mass vaccination or when infected. Failure to do so – for example, not warning that those with certain medical backgrounds might need special attention – could be seen as negligence if the science was available. Already, there are calls for acknowledging long COVID and PVS in informed consent for medical interventions. On the other hand, the complex nature of GASLIT-AF means it’s not a simple one-cause one-effect scenario, so establishing liability would require explaining these system dynamics in court. Nonetheless, as more evidence accrues (e.g. the Yale PVS study giving biologic credence to patient claims​[news.yale.edu](https://news.yale.edu/2025/02/19/immune-markers-post-vaccination-syndrome-indicate-future-research-directions#:~:text=%E2%80%9CThis%20work%20is%20still%20in,%E2%80%9D)), institutions may have to reckon with the fact that _ignoring patients’ chronic symptoms is ignoring a real, model-backed harm_. We may see an increase in disability claims and even legal action for long COVID as an occupational disease (for healthcare workers infected on the job) or vaccine injury in the rare cases it occurs, and the outcome of such claims will hinge on whether the harm was predictable and preventable.

**Policy Design and Breaking the Institutional Attractor:** Institutions (healthcare systems, insurers, employers, and governments) can themselves fall into an **“attractor” of inaction**. Historically, diseases like ME/CFS were marginalized for decades – an institutional equilibrium where minimal research funding, lack of provider education, and patient stigmatization reinforced each other. Long COVID initially risked the same, but the sheer scale of the pandemic is forcing a shift. To **break the institutional loop**, policies should address each reinforcing element:

- **Recognition and Classification:** Officially recognize post-COVID and post-vaccine syndromes as legitimate disease states. The WHO’s ICD-10 classification of “post-COVID condition” in 2021 was a step in this direction. Clear diagnostic criteria (potentially informed by models like GASLIT-AF) need to be disseminated, so that patients are no longer told “nothing is wrong” after normal basic labs. This recognition in policy documents breaks the cycle of gaslighting.
    
- **Surveillance and Risk Stratification:** Public health agencies should incorporate non-linear risk models. Instead of only tracking acute outcomes (death, hospitalization), track the incidence of long-term syndromes and identify clusters of risk factors. For example, if data show that young women with prior mononucleosis are at higher risk for long COVID (due to EBV reactivation mechanism), targeted messaging or early intervention (such as antivirals or immune modulation) could be implemented. This proactive approach contrasts with the current reactive or dismissive stance.
    
- **Research Funding and Interdisciplinary Approach:** Funding agencies should prioritize research that spans immunology, neurology, and endocrinology together – essentially, funding GASLIT-AF-oriented research. Additionally, patient registries and biobanks for Long COVID/PVS can accelerate understanding of γ, Λ, Ω factors. The NIH RECOVER initiative is one example, but it needs to incorporate complex systems analyses, not just search for single biomarkers. By investing in this, institutions move out of the attractor of “no evidence, so do nothing” towards “evidence is emerging, do something.”
    
- **Medical Education and Guidelines:** Clinicians need updated guidelines that reflect chronic post-viral syndromes as a diagnosis and provide management frameworks. Just as there are protocols for sepsis (acute positive feedback inflammation), there should be protocols for chronic systemic inflammation. For instance, guidance on POTS management in long COVID (fluids, salt, compression, beta blockers) should be disseminated at primary care level​[nature.com](https://www.nature.com/articles/s41569-023-00842-w#:~:text=POTS%20cannot%20be%20confirmed%20without,is%20usually%20complicated%20by%20other). When practitioners have a roadmap, they are less likely to dismiss patients. Institutions like hospitals and insurance companies should also update policies to accommodate these patients (e.g. allowing longer rehab, recognizing blood tests might be normal but tilt-table testing or cytokine panels might be needed).
    
- **Preventive Policy:** Perhaps the most forward-looking implication is to minimize triggering events in high-risk groups. If we identify someone with very high Ξ (say multiple autoimmune markers, high stress job, etc.), extra precautions could be taken: spacing out immunizations, offering anti-inflammatory prophylaxis around the time of vaccination or infection, aggressive early antiviral treatment during acute COVID to reduce viral persistence, etc. While speculative, these could reduce the chance of entering the bad attractor. On a larger scale, acknowledging that a fraction of people could be chronically disabled means policies like extended sick leave, disability benefits, and workplace accommodation become crucial. Some countries are already grappling with waves of people unable to return to work due to long COVID; treating this as a real outcome to plan for (rather than an anomaly) is an important policy shift.
    

In essence, breaking the institutional attractor loop means moving from a stance of **denial and diffusion of responsibility** to one of **anticipation and intervention**. GASLIT-AF, by elucidating that chronic syndromes are a systemic outcome of pandemic stressors, gives policymakers a framework to justify robust action. It turns “anecdotal” patient stories into a predictable scientific narrative – one that can inform better policy.

## Conclusion

We have presented the GASLIT-AF model as a comprehensive theoretical framework for understanding chronic post-COVID and post-vaccination syndromes, uniting concepts from systems biology, immunology, neurology, and complexity theory. By formalizing the interactions between the neuroimmune network, persistent antigens, and stress-feedback loops, GASLIT-AF explains how a temporary insult can lead to a stable, long-term pathological state in susceptible individuals. The model’s non-linear dynamics – characterized by feedback amplification, time delays, and thresholds – offer an explanation for the otherwise perplexing chronic illnesses that have followed the COVID-19 pandemic. They show why these conditions do not resolve on the expected timeline and why they have been historically overlooked by linear thinking.

Importantly, our synthesis demonstrates that this is not merely a theoretical exercise: every aspect of the model finds support in recent empirical findings, from the presence of spike protein in patients two years post-exposure​[news.yale.edu](https://news.yale.edu/2025/02/19/immune-markers-post-vaccination-syndrome-indicate-future-research-directions#:~:text=When%20the%20researchers%20measured%20levels,associated%20with%20long%20COVID%20as%C2%A0well), to the high incidence of EBV reactivation in long haulers​[clinicallab.com](https://www.clinicallab.com/long-covid-19-symptoms-likely-caused-by-epstein-barr-virus-reactivation-25749#:~:text=selected%20from%20those%20surveyed%2C%20that,001%2C%20Fisher%27s%20exact%20test), to objective signs of neuroinflammation and dysautonomia​[pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10378471/#:~:text=cerebellum,45)​[nature.com](https://www.nature.com/articles/s41569-023-00842-w#:~:text=tests2%20,have%20been%20also%20reported%2025), to identifiable genetic markers of risk​[immunologyresearchjournal.com](https://www.immunologyresearchjournal.com/articles/human-leukocyte-antigen-hla-at-the-root-of-persistent-antigens-and-long-covid#:~:text=Here%20we%20offer%20a%20perspective,COVID%20and%20pave%20the%20way)​[pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11562751/#:~:text=The%20Val158Met%20polymorphism%20was%20significantly,dopamine%20should%20be%20further%20explored). This convergence of evidence lends credibility to the idea of an irreversible attractor state – a specific “system failure mode” of the human body’s regulatory network triggered by the unique convergence of a novel virus, a global stress event, and individual susceptibilities.

The implications of GASLIT-AF are far-reaching. For clinicians and researchers, it provides a roadmap to navigate the complexity of post-COVID syndromes, suggesting multi-modal treatment strategies that simultaneously target immune triggers, autonomic dysfunction, and psychological stress loops. For patients, it offers validation: an understanding that their condition is _grounded in physiology_, even if standard tests are unrevealing – the equations might be complex, but the suffering is real and not “in their head.” For public health and policy, GASLIT-AF highlights the necessity of integrating systems thinking into preparedness: preventing and managing chronic illness outcomes should be part of the response to any future pandemics or mass vaccination campaigns. Finally, for the scientific community, this work underscores a paradigm shift in medicine that the COVID era may accelerate – embracing complex systems models to complement reductionist approaches, thereby capturing phenomena of emergence and persistence that single-factor models miss.

In conclusion, the GASLIT-AF model bridges the gap between patient experiences of being “gaslighted” and the formal scientific language needed to decode their condition. It turns the narrative of invisible illness into one of equations and state spaces, making the invisible visible. By recognizing chronic post-viral syndromes as an alternative stable state of human physiology – one that can be entered given certain parameters – we open the door to not only better understanding and empathy, but also to rational design of interventions to prevent and possibly even _reverse_ the collapse. The challenge ahead lies in operationalizing this framework: identifying individuals’ γ, Λ, and Ω in clinical practice, deploying treatments that alter feedback gains, and rigorously testing the model’s predictions. If successful, we may not only illuminate the pathogenesis of post-COVID conditions, but also pave the way for addressing other elusive chronic syndromes that have long vexed medicine. The hope is that by breaking these complex problems into system parameters and feedback loops, we can ultimately break the suffering of those trapped in the GASLIT-AF attractor.

**Sources:**

1. Puchhammer E, et al. (2022). _Allergy_, **77**(12): 3588-3590 – _Association between Epstein–Barr virus reactivation and Long-COVID fatigue_​[pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC9538037/#:~:text=prior%20to%20sampling%20,had%20recovered%20from%20their%20SARS%E2%80%90CoV%E2%80%902)​[pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC9538037/#:~:text=participants%20up%20to%2010%20weeks,in%20a%20sub%E2%80%90group%20of%20patients).
    
2. Gold JE, et al. (2021). _Pathogens_, **10**(6): 763 – _Evidence linking EBV reactivation to long COVID symptoms_​[clinicallab.com](https://www.clinicallab.com/long-covid-19-symptoms-likely-caused-by-epstein-barr-virus-reactivation-25749#:~:text=Epstein,published%20in%20the%20journal%20Pathogens)​[clinicallab.com](https://www.clinicallab.com/long-covid-19-symptoms-likely-caused-by-epstein-barr-virus-reactivation-25749#:~:text=selected%20from%20those%20surveyed%2C%20that,001%2C%20Fisher%27s%20exact%20test).
    
3. Iwasaki A, et al. (2025). medRxiv preprint – _Immune markers of post-vaccination syndrome (PVS)_​[news.yale.edu](https://news.yale.edu/2025/02/19/immune-markers-post-vaccination-syndrome-indicate-future-research-directions#:~:text=From%20participants%E2%80%99%20blood%20samples%2C%20the,blood%20cells%20%E2%80%94%20among%20other%C2%A0differences)​[news.yale.edu](https://news.yale.edu/2025/02/19/immune-markers-post-vaccination-syndrome-indicate-future-research-directions#:~:text=When%20the%20researchers%20measured%20levels,associated%20with%20long%20COVID%20as%C2%A0well).
    
4. Douaud G, et al. (2022). _Nature_, **604**: 697 – _Brain imaging and cognitive effects in COVID-19_ (neuroinflammation in limbic regions).
    
5. Nouraeinejad A, et al. (2023). _Acta Neurologica Belgica_, **123**(4): 1197 – _Hippocampal changes in COVID-19: microglial activation and neurogenesis loss_​[pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10208918/#:~:text=Since%20the%20hippocampus%20is%20predominantly,a%20window%20to%20explain%20memory).
    
6. Fernández-Castañeda A, et al. (2022). _Nature Neuroscience_, **25**: 1237 – _Mice with mild SARS-CoV-2 infection show sustained microglial activation, reduced hippocampal neurogenesis_.
    
7. Fedorowski A, et al. (2023). _Nat Rev Cardiology_, **20**(4): 251 – _Autonomic dysfunction (POTS) in post-acute COVID syndrome_​[nature.com](https://www.nature.com/articles/s41569-023-00842-w#:~:text=tests2%20,have%20been%20also%20reported%2025).
    
8. Su Y, et al. (2022). _Cell_, **185**(5): 881 – _Perturbed immune signaling in Long COVID, with low cortisol as a distinguishing feature_​[nih.gov](https://www.nih.gov/news-events/nih-research-matters/immune-hormonal-features-long-covid#:~:text=When%20the%20researchers%20used%20machine,levels%20of%20certain%20immune%20cells)​[nih.gov](https://www.nih.gov/news-events/nih-research-matters/immune-hormonal-features-long-covid#:~:text=reduced%20levels%20of%20certain%20immune,cells).
    
9. Georgopoulos AP, et al. (2023). _Immunology Research_, **1**(2): 13 – _HLA alleles at the root of persistent antigens in Long COVID_​[immunologyresearchjournal.com](https://www.immunologyresearchjournal.com/articles/human-leukocyte-antigen-hla-at-the-root-of-persistent-antigens-and-long-covid#:~:text=Here%20we%20offer%20a%20perspective,COVID%20and%20pave%20the%20way).
    
10. Taylor K, et al. (2023). _J Transl Med_, **21**: 775 – _Genetic risk factors for long COVID: 73 gene signatures (including TLR4)_​[translational-medicine.biomedcentral.com](https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-023-04588-4#:~:text=Among%20the%2073%20genes%20associated,with%20potential%20to%20protect%20against)​[translational-medicine.biomedcentral.com](https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-023-04588-4#:~:text=TLR4%20antagonists%20as%20repurposing%20candidates,treating%20long%20COVID%20and%2For%20ME%2FCFS).
    
11. Gerra MC, et al. (2024). _Pain_, **165**(12): 2541 – _COMT Val158Met polymorphism association with fibromyalgia and pain_​[pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11562751/#:~:text=The%20Val158Met%20polymorphism%20was%20significantly,dopamine%20should%20be%20further%20explored).
    
12. U.K. Office for National Statistics (2022). _Prevalence of ongoing symptoms following COVID-19 infection_.
